SCHEMBL25753487

SCHEMBL25753487

O=C(OCc1ccccc1)c1nc(Br)co1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.52
TDP1 Q9NUW8 4/20 0.50
KMT2A Q03164 2/20 0.50
SLC6A2 P23975 1/20 0.50
SLC6A3 Q01959 1/20 0.50
ALDH1A1 P00352 7/20 0.46
LMNA P02545 2/20 0.46
POLB P06746 1/20 0.43
L3MBTL1 Q9Y468 3/20 0.42
MAPK1 P28482 2/20 0.42
MMP2 P08253 2/20 0.41
MMP9 P14780 2/20 0.41
MMP12 P39900 2/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
MMP1 P03956 1/20 0.41
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22005652 0.82 TDP1 (0.50) TSHRTDP1KMT2ASLC6A2SLC6A3
SCHEMBL23596040 0.74 TSHR (0.54) TSHRTDP1KMT2ASLC6A2SLC6A3
SCHEMBL21588491 0.73 ALDH1A1 (0.56) TSHRTDP1KMT2ASLC6A2SLC6A3
SCHEMBL22423669 0.73 CES1 (0.56) TSHRTDP1KMT2ASLC6A2SLC6A3
SCHEMBL17965803 0.73 TDP1 (0.61) TSHRTDP1KMT2ASLC6A2SLC6A3
SCHEMBL14768871 0.72 TDP1 (0.66) TSHRTDP1KMT2ASLC6A2SLC6A3
SCHEMBL31636376 0.71 TDP1 (0.59) TSHRTDP1KMT2ASLC6A2SLC6A3
SCHEMBL27252996 0.71 TDP1 (0.54) TSHRTDP1KMT2ASLC6A2SLC6A3
SCHEMBL22005650 0.71 TDP1 (0.50) TSHRTDP1KMT2ASLC6A2SLC6A3
SCHEMBL19975800 0.71 TDP1 (0.54) TSHRTDP1KMT2ASLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691957-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691957-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CCNT1, CCNA1 TSHR 3200/4885TDP1 3145/4885KMT2A 2367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.